Guide for Authors
Submission of paper
Authors may choose to submit the manuscript as a single word file to be used in the refereeing process. Only when the submitted paper is at the revision stage, authors will be requested to put the paper into the correct format' for acceptance and provide the items required for the publication of the manuscript. The article types below are accepted for submission to Translational Research in Urology. Please ensure that manuscript you submit to Translational Research in Urology conforms to the Committee on Publication Ethics (COPE) and general Translational Research in Urology article requirements.
Contact details for submission
If authors are submitting a manuscript for publication in a special issue, please contact the Editor-in-Chief or Guest Editor for submission instructions. Please do not submit it through the online Translational Research in Urology unless authors are specifically instructed to do so.
Authorship credit should be based on (i) Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data, (ii) Drafting the article or revising it critically for important intellectual content; and (iii) Final approval of the version to be submitted for publication. All of these conditions should be met by all authors. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship. All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. All authors must agree on the sequence of authors listed before submitting the article. All authors must agree to designate one author as the corresponding author for the submission. It is the responsibility of the corresponding author to arrange the whole manuscript upon the requirements and to dialogue with the co-authors during the peer-reviewing and proofing stages and to also act on behalf.
Ethics in publishing
The ethical policy of Translational Research in Urology is based on the Committee on Publication Ethics (COPE) guidelines and complies with the International Committee of Translational Research in Urology Editorial Board codes of conduct. Readers, authors, reviewers, and editors should follow these ethical policies once working with Translational Research in Urology. The ethical policy of Translational Research in Urology is liable to determine which of the typical research papers or articles submitted to the journal should be published in the concerned issue. The publishing decision is based on the suggestion of the journal's reviewers and editorial board members. The ethical policy insisted the Editor-in-Chief, may confer with other editors or reviewers in making the decision. The reviewers are necessary to evaluate the research papers based on the submitted content confidentially. The reviewers also suggest the authors improve the quality of the research paper by their reviewing comments. Authors should ensure that their submitted research work is original and has not been published elsewhere in any language. Applicable copyright laws and conventions should be followed by the authors. Any kind of plagiarism constitutes unethical publishing behavior and is unacceptable. For information on this matter in publishing and ethical guidelines please visit http://publicationethics.org.
To sustain the peer review system, authors should participate in the peer-review process to evaluate manuscripts from others. When appropriate, authors are obliged to provide retractions and/or corrections of errors to the editors and the Publisher. All papers submitted to Translational Research in Urology journal will be peer-reviewed for at least one round. Translational Research in Urology journal adopts a double-blinded review policy: authors are blind to reviewers, and reviewers are not blind to authors as well. The peer-review process is conducted in the online manuscript submission and peer-review system. After a manuscript is submitted to the online system, the system immediately notifies the editorial office. After passing an initial quality check by the editorial office, the manuscript will be assigned to two or more reviewers. After receiving reviewers’ comments, the editorial team member makes a decision. Because reviewers sometimes do not agree with each other, the final decision sent to the author may not exactly reflect recommendations by any of the reviewers.
The decision after each round of peer review may be one of the following:
In addition to Rapid Peer Review Process, the Translational Research in Urology Journal has Post-Publication Evaluation by the scientific community. Post-Publication Evaluation is concentrated to ensure that the quality of published research, review, and case report meets certain standards and the conclusions that are presented are justified. The post-publication evaluation includes online comments and citations on published papers. Authors may respond to the comments of the scientific community and may revise their manuscript. The Post-Publication Evaluation is described in such a way; it is allowing authors to publish quickly about Environmental science, management, engineering, and technology concepts.
Preparation of manuscripts
Manuscripts must be submitted only in English and should be written according to sound grammar and proper terminology. Manuscripts should be typed in double-spaced Times New Roman of 12 pt. Font and in MS-Word format in one column with a 2.5 cm margin at each side. Manuscript submission must be applied once to obtain only one submission ID number. More than one submission for a single manuscript can lose the chance of manuscript consideration. The manuscript must be accompanied by a covering letter including the title and author(s) name.
All publications in Translational Research in Urology are in the English language. Authors whose first language is not English should make sure their manuscript is written in idiomatic English before submission. Please write your text in good English (American or British usage is accepted, but not a mixture of these). No language and copyediting services are provided by the Translational Research in Urology; hence, authors who feel their manuscript may require editing to eliminate possible grammatical or spelling errors are encouraged to obtain such services before submission. Authors are responsible for all costs associated with such services.
All manuscripts must contain the essential elements needed to convey your manuscript, for example, Structured Abstract, Keywords, Introduction, Methods, Results and Discussion, Conclusions, Authors' contributions, Acknowledgement, Conflicts of Interest Disclosures, Funding, and Ethical statements. Artwork and Tables with Captions. Please ensure all figures (JPEG/PDF), tables (Docx) are uploaded separately and just their captions or legends are at the end of the main manuscript file after the reference list.
Manuscript submission and declaration
While submitting a manuscript to Translational Research in Urology, all contributing author(s) must verify that the manuscript represents authentic and valid work and that neither this manuscript nor one with significantly similar content under their authorship has been published or is being considered for publication elsewhere including electronically in the same form, in English or other languages, without the written consent the copyright holder. All authors have agreed to allow the corresponding author to serve as the primary correspondent with the editorial office, to review the edited manuscript and proof. All contributing authors must complete and submit an Authorship Statement Form once submitting a manuscript to the Translational Research in Urology.
Manuscripts are assumed not to be published previously in print or electronic versions and are not under consideration by another publication. Copies of related or possibly duplicated materials (including those containing significantly similar content or using the same data) that have been published previously or are under consideration for another publication must be provided at the time of online submission.
Original Research articles report on primary and unpublished studies. Original Research may also encompass confirming studies and disconfirming results which allow hypothesis elimination, reformulation and/or report on the non-reproducibility of previously published results. Original Research articles should have the following format: 1) Abstract, 2) Introduction, 3) Methods, 4) Results, 5) Discussion
Clinical Trial articles describe the results of interventional studies related to health. These articles can include pilot studies, safety and efficacy trials, surrogate endpoint studies, and proof-of concept studies. Clinical Trial articles should have the following format: 1) Abstract (please include the clinical trial registry number), 2) Introduction, 3) Methods (including flow diagram when applicable, for example the CONSORT FLOW DIAGRAM- http://www.consort-statement.org/consort-statement/flow-diagram), 4) Results, 5) Discussion. All clinical trials must be registered in a public trials registry and Registered Randomized Clinical Trial Code (RCT) should be provided, and authors should be compliant with the Consolidated Standards of Reporting Trials (CONSORT).
Systematic Review articles present a synthesis of previous research, and use clearly defined methods to identify, categorize, analyze and report aggregated evidence on a specific topic. Systematic Reviews should: clearly define the research question in terms of population, interventions, comparators, outcomes and study designs, and state which reporting guidelines were used in the study. For design and reporting, systematic reviews must conform to the reporting guidelines (PRISMA), and include the PRISMA flow diagram http://prisma-statement.org/prismastatement/flowdiagram.aspx. Systematic Reviews should have the following format: 1) Abstract, 2) Introduction, 3) Methods (including study design; participants; interventions; search strategy; data sources; study sections and data extraction; data analysis), 4) Results (including a flow diagram of the studies retrieved for the review; study selection and characteristics; synthesized findings; assessment of risk of bias), 5) Discussion (including summary of main findings; limitations; conclusions).
Review articles cover topics that have seen significant development or progress in recent years, with comprehensive depth and a balanced perspective. Review articles should have the following format: 1) Abstract, 2) Introduction, 3) Subsections relevant for the subject, 4) Conclusion. Review articles must not include unpublished material (unpublished/original data, submitted manuscripts, or personal communications) and may be rejected in review or reclassified, at a significant delay, if found to include such content.
Case Reports highlight unique cases of human patients that present with an unexpected/ diagnosis, treatment outcome, or clinical course. Authors should follow the CARE guidelines and submit a completed CARE checklist as a supplementary file (template available here: https://www.care-statement.org/checklist). Case Reports should have the following format: 1) Abstract, 2) Introduction, 3) Case presentation: including de-identified patient information, relevant physical examination and other clinical findings, relevant past interventions and their outcomes, 4) Discussion. Authors are required to obtain written or verbal informed consent from the patients (or their legal representatives) for the publication.
The Editorial should present the contributing articles of the Research Topic but should not be a mere table of contents. As the final contributing article to the Research Topic, Editorials should be submitted once all expected articles have been accepted and published. Editorials should not include unpublished or original data and the inclusion of references is strongly encouraged.
In the Translational Research in Urology journal several article types are published so the standard format of the journal will be changed based on the manuscript type. The following part is a general format based on the original / research articles. Manuscript literature and tenses must be structured as Title, Structured Abstract, Keywords, Introduction, Methods, Results, and Discussion, Conclusions, Authors' contributions, Acknowledgement, Conflicts of Interest, Funding, Ethical statements, References. Artwork and Tables with Captions. Please ensure all figures (JPEG/PDF), tables (Docx) are uploaded separately and just their captions or legends are at the end of the main manuscript file after the reference list. Title no more than 25 words and main words’ initials in the capital, All authors and their affiliations. Moreover, the corresponding should have a name, address, telephone, fax, email.
Please make sure your title page contains the following information.
The title of up to 25 words with no abbreviations and main words with capital initials. Avoid complicated and technical expressions and do not use vague expressions. The title should be oriented to Translational Research in Urology.
An abstract of 150 to 300 words (for Editorial/letter 75-150 words) that sketch the purpose of the study; basic procedures; the main findings its novelty; discussions and the principal conclusions, should not contain any undefined abbreviations (the number of abbreviations should be the minimum) or references. STRUCTURED ABSTRACT content structures must be made according to Introduction, Methods, Results, and Conclusions. For case reports/presentations the structure is; Introduction, case presentation, conclusions. For review and letters/ editorials, an unstructured abstract is needed. With no citations or references.
Provide 3 to 7 keywords that can be used for indexing purposes. Keywords should not repeat the words of the manuscript title or contain abbreviations and shall be written with capital initials separated by a semicolon.
Highlights are mandatory for Translational Research in Urology journal. A highlight is a concise, short phrase, conveying the core findings of your research. Please use 'Highlights' in the file name and include 2 to 5 items. The approximate length of each highlighted item maybe within two lines. Highlights should be uploaded as a separate word file.
The Introduction should state the purpose of the investigation and identify the gap of knowledge that will be filled in the Literature review study. The date and location of the research carried out throughout the study must be mentioned at the end of this section.
The methods section should provide enough information to permit the repetition of the experimental work. It should include clear descriptions and explanations of sampling procedures, experimental design, and essential sample characteristics and descriptive statistics, the hypothesis tested, exact references to literature describing the tests used in the manuscript, the number of data involved in statistical tests, etc.
For review articles, Editorials/Letters, and case reports the headings of the main text are different. Editorial should start with the editor/Editorial and end with conclusions. Review article had their own headings with search strategy (optional), and conclusions. The case report should contain an Introduction, Case presentations, Methods (optional), and Conclusions.
Results and Discussion
The Results section should describe the outcome of the study. Data should be presented as concisely as possible if appropriate in the form of tables or figures, although very large tables should be avoided. The Discussion should be an interpretation of the results and their significance concerning work by other authors. Please note that the policy of the Journal concerning units and symbols is that of SI symbols. For review articles, Editorials/Letters, and case report the headings of the main text are different. Editorial should start with the editor/Editorial and end with conclusions. Review article had their own headings with search strategy (optional), and conclusions. Case report should contain Introduction, Case presentations, Methods (optional), Conclusions.
Do not submit tables and graphs as photographs. Tables should be set within the text. Do not use internal horizontal and vertical rules. Tables should be set within the text and should have a clear and rational structure along with consecutive numerical order. All tables should be numbered (1, 2, 3, etc.). Give enough information in subtitles so that each table is understandable without reference to the text. For each table, please supply a table caption (title) explaining the components of the table and explanations (optional). Identify any previously published material by giving the original source in the form of a reference at the end of the table caption. Tables should be with the captions placed above in limited numbers. Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data).
Figures should be cited in the text. Figures/ illustrations should be in high-quality artwork, within 200-300 dpi, and separately provided in Excel format. Ensure that figures are clear, labeled, and of a size that can be reproduced legibly in the journal. Figures should be set within the text. Following remarks should be applied to the figures:
This section should highlight the major, firm discoveries, and state what the added value of the main finding is, without literature references.
Specify the contribution of each author of the manuscript performances. Write the contributor initials and surname of each author along with their role in the manuscript participation.
Acknowledgments of people, grants, funds, etc. should be placed in a separate section before the reference list.
Conflict of interest
Further information on the Conflict of Interest Disclosure form can be found in the Conflict of Interest Form.
Authors are requested to identify who provided financial support for the conduct of research and/or preparation of the article and briefly describe the role of the funder/sponsor in any part of the work including design and conduct of the study, data collection, data management, data analysis and interpretation, preparation, review, and approval of the manuscript. The following rules should be followed:
Personal ethics are moral guidelines that can help you through tough situations and make the best decisions. Personal ethics is the code of ethical guidelines that guide you in your personal and professional life. They often develop from your core values and work ethic into actionable goals used in a variety of challenging situations. Ethical statements for Editorials, Letters, and review (systematic or narrative) are not included.
The list of all abbreviations which are used in the manuscript text should be defined in the text at first use (Avoid addition of abbreviation in the manuscript abstract). The list of abbreviations (nomenclatures) must be provided alphabetically. If your manuscript does not contain any abbreviation, just state “Not applicable” in this section.
References list must be provided by EndNote (https://endnote.com/downloads/) according to the Translational Research in Urology reference format in a consistent style (Vancouver). Where applicable, author(s) name(s), year of publication, journal abbreviated title/ book title, chapter title/article title, volume and issue numbers/ book chapter, and the pagination must be present. Groups of references should be listed first alphabetically, then chronologically. The number of references extracted from each journal should not exceed 3 to 5 citations, which is the average acceptable amount. It is also substantially recommended to the authors to refer to recent references in the last 10 years rather than old and out-of-date ones. Volume, issue, and pages of the whole references must be specified according to the Translational Research in Urology format.
All contributing authors should qualify for authorship. The order of authorship should be a joint decision of the co-authors. Sufficient participation in the work is of utmost importance Authorship.
Authorship credit should be based on substantial contribution to conception and design, execution, or analysis and interpretation of data. All authors should be involved in drafting the article or revising it critically for important intellectual content, must have read and approved the final version of the manuscript, and approve of its submission to this journal.
Before the accepted manuscript is published in an online issue
Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) signed TRU change to Authorship Form by all authors that they agree with the addition, removal or rearrangement.
After the manuscript is submitted or accepted for publication, the corresponding author confirmed proof of the article there is no way to change the authors and their orders.
After the accepted manuscript is published in an online issue
Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
Journals should make clear the type of copyright under which the author's work will be published. Upon acceptance of the manuscript, authors will be asked to complete a 'Journal Publishing Agreement' Translational Research in Urology. Copyright Transfer Agreement Form
An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement. Permission should be sought from the publisher to reproduce any substantial part of a copyrighted work that depends on both the significance of the material and the quantity of material used. This includes any text, illustrations, charts, tables, photographs, or other material from previously published sources used. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners (publisher) and credit the source(s) in the manuscript.
Permission not required
Copyright protects only original (i.e. creative) material. As such it protects only the particular form of expression of work and not the ideas or facts contained in it. Public domain works are not protected by copyright and may be reproduced without permission. Permission would however be required to re-use the final formatted, edited, published version of the work in certain cases, as it is owned by the publisher.
Open Access Publication
Translational Research in Urology publishes the research work, covering a wide range of academic disciplines. All papers published in Translational Research in Urology are open access and distributed under the open-access license agreement (create the open-access license agreement form). Under this license, authors retain ownership of the copyright for their content but allow anyone to download, reuse, reprint, modify, distribute, and/or copy the content as long as the original authors and source are cited properly. There are two distinct types of licenses viz., author agreement and user agreement, which are needed to be defined during the open access publication process. For open access articles, the publisher uses an exclusive licensing agreement in which authors retain copyright in their manuscripts.
Plagiarism Prevention and Violation of Publication Ethics
All manuscripts under review or published with Translational Research in Urology are subject to screening using Plagiarism Prevention Software called iThenticate. Plagiarism is a serious violation of publication ethics. Other violations include duplicate publication, data fabrication and falsification, and improper credit of author contribution. Thus, Plagiarism or Fraudulent or knowingly inaccurate statements that constitute unethical behavior are unacceptable, and submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. It is necessary to mention that Translational Research in Urology Journal may ignore a duplicated manuscript of ≥ 15-20%.
The development of Cross Check is a service that helps editors to verify the originality of papers. CrossCheck is powered by software from iParadigms, known in the academic community as providers of Turnitin. For a searchable list of all journals in the CrossCheck database, please visit www.ithenticate.com/search.
The covering letter contains the title of the manuscript, corresponding author, and participated in other author’s detail, an area of study, and type of manuscript. Further, the corresponding author should be declared that the prepared manuscript is by the Translational Research in Urology guide for authors.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string that is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes, i.e., When the authors use a DOI to create links to documents on the web, the DOIs are guaranteed never to change.
Online proof correction
Corresponding authors will receive an e-mail with a link to our online proofing system, allowing annotation and correction of proofs online. The environment is similar to MS Word: in addition to editing text, you can also comment on figures/tables and answer questions from the Copy Editor. Use this proof only for checking the typesetting, editing, completeness, and correctness of the text, tables, and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor-in-Chief. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as the inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely the corresponding author's responsibility.